Newsroom
301 articles
FeaturedThe European Medicines Agency (EMA) has suggested expanding the use of Ofev (nintedanib) to treat progressive fibrosing interstitial lung disorders (ILDs) in children and adolescents starting at age…
FeaturedThe updated regulatory framework will expedite trial approvals and promote trial design innovation without affecting patient safety. New laws will be introduced in Parliament to address the need…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine flortaucipir (Tauvid), a radiopharmaceutical product given to adults with memory problems so that doctors can perform…
FeaturedFollowing a review of its initial opinion, EMA suggests revising the recommendations to reduce the possibility of interactions between the weight loss medication Mysimba (naltrexone/bupropion) and medications that…
FeaturedThe U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), a gene therapy based on an adeno-associated virus vector that is recommended for the treatment of patients with…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved new medicine containing active ingredient sparsentan to treat primary immunoglobulin A nephropathy (IgAN). IgA neuropathy, also known as…
FeaturedAfter an agency analysis of the available evidence found that oral phenylephrine is ineffective for this use, The U.S. Food and Drug Administration announced is proposing to remove…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) is advising medical practitioners to make sure patients are informed about the known adverse effects of agonists of the glucagon-like…
FeaturedSugemalimab, also known as(Equijubi), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat adult patients with “non-small cell lung cancer.” Non-small cell lung…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) has authorized elafibranor (Iqirvo) for the treatment of adult patients suffering from primary biliary cholangitis (PBC), a rare form of…
FeaturedHympavzi (marstacimab-hncq) was approved by the U.S. Food and Drug Administration for routine prophylactic use in patients aged 12 and up who have hemophilia A without factor VIII…
FeaturedAn adult COVID-19 vaccine (Comirnaty) that targets the KP.2 subvariant has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA). The immune system’s generation of antibodies…
FeaturedPatients who use insulin pumps or continuous glucose monitors (CGMs) are being asked by the Medicines and Healthcare Products Regulatory Agency (MHRA) to promptly report any safety issues…
FeaturedMarketing permission for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test was given by the U.S. Food and Drug Administration. The test is approved for use without a…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated phosphoinositide 3-kinase delta syndrome or APDS…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP